Mahsa Etemadi

Mahsa Etemadi

Auto-generated profile, based on publicly available information

Mahsa Etemadi

Department of Periodontics, School of Dentistry Mashhad University of Medical Sciences Mashhad Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Journal of Advanced Periodontology & Implant Dentistry
Verified
Journal Article
Open access
HKHossein Khoshkhou
Hossein Khoshkhou
SYSiamak Yaghobee
Siamak Yaghobee
MFMohammadjavad Kharrazi Fard
Mohammadjavad Kharrazi Fard
MEMahsa Etemadi
Mahsa Etemadi
SMSeyed Hossein Mohseni Salehi Monfared
Seyed Hossein Mohseni Salehi Monfared
Background. The importance of peri-implant soft tissues in maintaining tissue health and aesthetics has been recognized. A thickness of at least 2 mm is considered a protective factor against peri-implantitis. This study assessed clinical outcomes and complications at implant sites following soft tissue augmentation with either palatal free gingival graft (FGG) or palatal pedicle graft (PPG). Methods. In this randomized controlled clinical trial, 42 patients with inadequate keratinized tissue width (KTW) were randomly assigned to two intervention groups: Group 1 received FGGs, while group 2 underwent PPGs. The KTW, vestibular depth, and surface shrinkage were recorded preoperatively and one and three months after the operation. Patient-reported outcome measurements were recorded at a two-week follow-up. Results. Thirty-five patients completed the study (FGG group, n=17; PPG group, n=18). Group 2 demonstrated a higher increase in KTW and vestibular depth at 1 and 3 months (P0.05). The number of analgesics in each group was not significantly different two weeks after the operation; however, the Numeric Pain Rating Scale (NPRS) showed significantly higher pain scores on days 3 to 8 in group 1 patients. Conclusion. The use of PPG in soft tissue augmentation demonstrated more KTW formation and less postoperative morbidity. There was no difference between the methods used to compare surface shrinkage.

25 August 2026 in Clinical and Experimental Dental Research
Verified
Journal Article
Open access
MBMahdi Bahrami
Mahdi Bahrami
MEMahsa Etemadi
Mahsa Etemadi
RAReyhaneh Abrishami
Reyhaneh Abrishami
FAFarshad Alipour
Farshad Alipour
SHShiva Hadizadeh
Shiva Hadizadeh
Edris PordelEdris Pordel
Edris Pordel
Objectives: This study aimed to evaluate the available clinical evidence on the use of ozonated gels and oils in the management of periodontitis. Material and Methods: Embase, SCOPUS, Web of Science, PubMed, and Google Scholar were searched up to May 13, 2025. Original peer‐reviewed randomized controlled trials (RCTs) in English that investigated patients with periodontitis were included. Study characteristics, methods of ozone application, conclusions, and reported complications were extracted. Pooled mean differences of clinical indices were compared between the ozone therapy groups (adjunctive or monotherapy) and control groups (placebo or CHX). Primary outcomes included clinical indices such as probing pocket depth (PPD), plaque index (PI), and gingival index (GI), whereas secondary outcomes comprised clinical attachment level (CAL), clinical attachment loss (CAtL), bleeding on probing (BoP), and sulcus bleeding index (SBI). Results: Of the 962 records, 19 clinical studies were included in the qualitative synthesis and 18 RCTs in the quantitative synthesis. For periodontitis, ozonated compounds significantly reduced PPD when used as an adjunct to subgingival instrumentation (MD = −0.780; p < 0.0001) and reduced clinical attachment loss (CAL) (MD = −0.457; p = 0.001) compared with subgingival instrumentation alone. No statistically significant differences were observed in PI or GI outcomes with ozonated compounds as an adjunct to subgingival instrumentation compared with subgingival instrumentation alone, although sensitivity analyses indicated some instability in the results. Follow‐up periods ranged from 4 to 12 weeks across outcomes (8–12 weeks for GI), with most studies reporting 12‐week follow‐up. No consistent differences were found between ozone and CHX in terms of PPD, CAL, PI or BoP. No adverse effects were reported in the studies. Conclusions: Ozonated gels and oils were associated with favorable periodontal outcomes, particularly when used as adjuncts to subgingival instrumentation, and no major adverse effects were reported. However, the evidence is limited by short‐term follow‐up and methodological heterogeneity.